The Journal of Experimental Medicine
for flow cytometry > invitrogen
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 206K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lucchiari-Hartz, M.
Right arrow Articles by Niedermann, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lucchiari-Hartz, M.
Right arrow Articles by Niedermann, G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ACETYLCYSTEINE
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/2000/1/239/ $5.00
The Journal of Experimental Medicine, Volume 191, Number 2, January 17, 2000 239-252


Original Article

Cytotoxic T Lymphocyte Epitopes of HIV-1 Nef: Generation of Multiple Definitive Major Histocompatibility Complex Class I Ligands by Proteasomes



Maria Lucchiari-Hartza, Peter M. van Endertb, Grégoire Lauvaub, Reinhard Maierc, Andreas Meyerhansc, Derek Mannd, Klaus Eichmanna, and Gabriele Niedermanna

a Max-Planck Institute of Immunobiology, D-79108 Freiburg, Germany
b Institut National de la Santé et de la Recherche Médicale (INSERM) U25, Hôpital Necker, 75743 Paris Cedex 15, France
c Institute for Microbiology and Hygiene, Department of Virology, The Saarland University Hospital, D-66421 Homburg, Germany
d Department of Clinical Biochemistry, University of Southampton School of Medicine, Southampton SO16 7PX, United Kingdom
Max-Planck Institute of Immunobiology, Stübeweg 51, D-79108 Freiburg, Germany.49-761-5108-54549-761-5108-435

niedermann{at}immunbio.mpg.de

Although a pivotal role of proteasomes in the proteolytic generation of epitopes for major histocompatibility complex (MHC) class I presentation is undisputed, their precise function is currently the subject of an active debate: do proteasomes generate many epitopes in definitive form, or do they merely generate the COOH termini, whereas the definitive NH2 termini are cleaved by aminopeptidases? We determined five naturally processed MHC class I ligands derived from HIV-1 Nef. Unexpectedly, the five ligands correspond to only three cytotoxic T lymphocyte (CTL) epitopes, two of which occur in two COOH-terminal length variants. Parallel analyses of proteasomal digests of a Nef fragment encompassing the epitopes revealed that all five ligands are direct products of proteasomes. Moreover, in four of the five ligands, the NH2 termini correspond to major proteasome cleavage sites, and putative NH2-terminally extended precursor fragments were detected for only one of the five ligands. All ligands are transported by the transporter associated with antigen processing (TAP). The combined results from these five ligands provide strong evidence that many definitive MHC class I ligands are precisely cleaved at both ends by proteasomes. Additional evidence supporting this conclusion is discussed, along with contrasting results of others who propose a strong role for NH2-terminal trimming with direct proteasomal epitope generation being a rare event.

Key Words: proteasome • HIV Nef • cytotoxic T lymphocyte epitopes • antigen processing • naturally processed peptides


The nomenclature for the amino acid residues of protease substrates with respect to the scissile bond is P3-P2-P1—cleavage site—P1'-P2'-P3'.

Abbreviations used in this paper: aa, amino acid(s); ER, endoplasmatic reticulum; FR, fluorescence ratio; IC50, 50% inhibition of specific binding; LAP, leucine aminopeptidase; Nt, NH2-terminally; PA28, proteasome activator 28; rp-HPLC, reversed phase HPLC; TAP, transporter associated with antigen processing; TPP II, tripeptidyl peptidase II.

© 2000 The Rockefeller University Press


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS